Literature DB >> 12628098

[Childhood immunization schedule of the Spanish Association of Pediatrics 2003].

.   

Abstract

In this document the Advisory Committee on Vaccines of the Spanish Association of Pediatrics provides recommendations for the immunization schedule for the 2003-2004 season. The use of inactivated poliovirus vaccine is again stressed for children of any age. Moreover, the introduction of the varicella vaccine and the pneumococcal conjugated vaccine, as well as the option of dTpa in adolescents, is highly recommended due to the availability of safe and effective products. Because of the increasing number of new vaccines in the immunization schedule, strategies with combined vaccines must be used.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12628098

Source DB:  PubMed          Journal:  An Pediatr (Barc)        ISSN: 1695-4033            Impact factor:   1.500


  3 in total

1.  Safety, reactogenicity, and immunogenicity of live attenuated varicella vaccine in children between 1 and 9 years of age with atopic dermatitis.

Authors:  Hans Wolfgang Kreth; Peter Hans Hoeger
Journal:  Eur J Pediatr       Date:  2006-07-12       Impact factor: 3.860

2.  Meningococcal Vaccination Rates Among People With a New Diagnosis of HIV Infection in the US.

Authors:  Parinaz K Ghaswalla; Gary S Marshall; Lindsay G S Bengtson; Ami R Buikema; Tim Bancroft; Eleena Koep; Patricia Novy; Cosmina S Hogea
Journal:  JAMA Netw Open       Date:  2022-04-01

3.  Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months.

Authors:  Fred Zepp; Ulrich Behre; Klaus Kindler; Karl-Heinz Laakmann; Heidemarie Pankow-Culot; Wilma Mannhardt-Laakmann; François Beckers; Dominique Descamps; Paul Willems
Journal:  Eur J Pediatr       Date:  2007-05-31       Impact factor: 3.860

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.